Bellevue-based shipping startup Pandion has closed. Pandion founder and CEO Scott Ruffin announced the decision earlier this month on LinkedIn. The move comes after the company raised multiple ...

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

ROCHESTER, NY, [January 14, 2025] – This month, Pandion Optimization Alliance celebrates 100 years of bringing organizations together, marking an extraordinary journey that began as a rural hospital ...